C7 - complement component 7 Gene
Also Known as Gm1238; A530026G17
生物種: Mus musculus
遺伝子タイプ: protein coding
遺伝子ID: 109828
Summary
Predicted to be part of membrane attack complex. Human ortholog(s) of this gene implicated in Complement Component 7 deficiency. Orthologous to human C7 (complement C7). [provided by Alliance of Genome Resources, Apr 2022]
C7 Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_001243837.1 | NP_001230766.1 | complement component C7 precursor |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
complement component C7 |
|
Related Agents
- Approval
- Clinical Phase
- Pre-clinical Phase
Approval
Clinical Phase
Pre-clinical Phase
Bioactive Molecules
(105)
| 製品番号 | 製品名 |
製品効果
|
純度 |
Rare Diseases
|
|---|---|---|---|---|
| HY-150745A | ODN 24987 sodium | 99.08% | Unkown | |
| HY-120991 | 1-Palmitoyl-2-linoleoyl-sn-glycero-3-PE | 98.0% | Unkown | |
| HY-W088194 | Boc-C7-COOH | 99.33% | Unkown | |
| HY-W668775 | Quin-C7 | Antagonist | 99.76% | Unkown |
| HY-148671 | (S,R,S)-AHPC-amido-C7-acid | 98.71% | Unkown | |
| HY-150746A | ODN 24991 sodium | 99.64% | Unkown | |
| HY-W008821 | 1,7-Heptanediamine | Inhibitor | ≥98.0% | Unkown |
| HY-149577 | EBV lytic cycle inducer-1 | Inducer | 96.25% | Unkown |
| HY-147128 | PY109 | Agonist | 99.15% | Unkown |
| HY-P10501A | FRα-targeting peptide C7 TFA | 99.85% | Unkown | |
| HY-133799 | Pomalidomide-C7-COOH | 95.35% | Unkown | |
| HY-136005 | VH032-C7-COOH | 99.92% | Unkown | |
| HY-150746 | ODN 24991 | Inhibitor | 99.64% | Unkown |
| HY-B0315S | Vitamin B12-13C7 | 96.14% | Unkown | |
| HY-P3801 | [Glp5,(Me)Phe8,Sar9] Substance P (5-11) | Modulator | 99.61% | Unkown |
| HY-W012340S | H-HomoArg-OH-13C7,15N4 hydrochloride | Inhibitor | 98.0% | Unkown |
| HY-130640 | (S,R,S)-AHPC-Me-C7 ester | 95.49% | Unkown | |
| HY-131874 | Thalidomide-O-C7-acid | Inducer | 98.55% | Unkown |
| HY-131878 | Pomalidomide-C7-NH2 hydrochloride | 98.97% | Unkown | |
| HY-150745 | ODN 24987 | Inhibitor | / | Unkown |
| HY-163678 | Pomalidomide-CO-C7-NH-CO-C3-COOH | 98.55% | Unkown | |
| HY-16676 | 7-Epi-docetaxel | Activator | 98.76% | Unkown |
| HY-176224 | Anti-virulence factor-IN-2 | Inhibitor | 98.41% | Unkown |
| HY-P10501 | FRα-targeting peptide C7 | / | Unkown | |
| HY-RS03384 | CXCL10 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W011103 | Diheptyl phthalate | 98.64% | Unkown | |
| HY-W016087 | Monoethyl pimelate | / | Unkown | |
| HY-130949B | Thalidomide-4-O-C7-NH2 hydrochloride | 99.80% | Unkown | |
| HY-N6802 | Tigloylgomisin H | Inducer | 98.37% | Unkown |
| HY-130949 | Thalidomide-4-O-C7-NH2 | Inducer | / | Unkown |
| HY-128746S | 2,6-Diaminoheptanedioic acid-13C7,15N2 | / | Unkown | |
| HY-131622S | 7-Aminoclonazepam-13C6 | / | Unkown | |
| HY-131740 | 2'-Deoxytubercidin 5'-triphosphate | / | Unkown | |
| HY-131740A | 2'-Deoxytubercidin 5'-triphosphate sodium | / | Unkown | |
| HY-136186 | (S,R,S)-AHPC-C7-amine | / | Unkown | |
| HY-136186B | (S,R,S)-AHPC-C7-amine hydrochloride | / | Unkown | |
| HY-149564 | Thalidomide-5-O-C7-NH2 hydrochloride | Inducer | 98.13% | Unkown |
| HY-149645 | CB2 receptor antagonist 2 | Antagonist | / | Unkown |
| HY-151274 | SARS-CoV-2-IN-28 | Inhibitor | / | Unkown |
| HY-151274A | SARS-CoV-2-IN-28 disodium | Inhibitor | / | Unkown |
| HY-151468 | AIE-Cbz-LD-C7 | / | Unkown | |
| HY-153541 | AP-C7 | Inhibitor | / | Unkown |
| HY-155263 | Pomalidomide-5-C7-NH2 hydrochloride | / | Unkown | |
| HY-155527 | SARS-CoV-2 Mpro-IN-9 | Inhibitor | 99.31% | Unkown |
| HY-155560 | Pomalidomide-C7-NH2 | / | Unkown | |
| HY-157437 | AChE/BChE-IN-16 | Inhibitor | / | Unkown |
| HY-157883 | C7BzO | Inhibitor | / | Unkown |
| HY-161379 | CLZX-205 | Inhibitor | / | Unkown |
| HY-161663 | Phosphodiesterase-IN-2 | Inhibitor | / | Unkown |
| HY-161933 | 1-Adamantane-amide-C7-NH2 | / | Unkown | |
| HY-163758 | COOH-C3-CONH-C7-COOH | / | Unkown | |
| HY-163984 | Antibacterial agent 240 | Inhibitor | / | Unkown |
| HY-164799 | FXR agonist 12 | Agonist | / | Unkown |
| HY-167694 | Antiproliferative agent-62 | Activator | / | Unkown |
| HY-169006 | Evo312 | / | Unkown | |
| HY-173580 | 7-Deaza-2'-deoxyadenosine-5'-O-triphosphate tetrasodium | / | Unkown | |
| HY-174869 | Pomalidomide-5-C7-NH2 | / | Unkown | |
| HY-175241 | T-01-C7-amide | / | Unkown | |
| HY-176470 | Thalidomide-N-C-piperidine-C7-Br | / | Unkown | |
| HY-179720 | TT-012-NH-C7-NHBoc | / | Unkown | |
| HY-181189 | Lenalidomide-C7-NH2 | / | Unkown | |
| HY-181868 | Lenalidomide-CO-C7-NH2 | / | Unkown | |
| HY-181882 | MV78-OH-C7-COOH | / | Unkown | |
| HY-186154 | Thalidomide-amine-C7-acid | / | Unkown | |
| HY-187177 | Pomalidomide-C2-NHCO-C7-NHBoc | / | Unkown | |
| HY-189842 | PC-C7 | Inhibitor | / | Unkown |
| HY-CE01248 | C7:0-CoA | / | Unkown | |
| HY-E71528 | 2-epi-5-epi-Valiolone synthase | / | Unkown | |
| HY-N19150 | Cordybislactone hydrolyzed derivative-1 | / | Unkown | |
| HY-N21623 | Bambulignan B | / | Unkown | |
| HY-N6779S | Patulin-13C7 | / | Unkown | |
| HY-N7777 | 7-Xylosyl-10-Deacetyltaxol C | / | Unkown | |
| HY-P3972 | H-ILE-ARG-VAL-VAL-MET-OH | / | Unkown | |
| HY-P992563 | Anti-Mouse CCR7/CD197 Antibody (C7Mab-2) | Inhibitor | / | Unkown |
| HY-RS01753 | C7 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS01754 | C7orf50 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS05971 | H3C7 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS12598 | SDR9C7 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W142432S | Perfluoroundecanoic acid-13C7 | / | Unkown | |
| HY-W334800S | (2S,6S)-2,6-Diaminoheptanedioic acid-13C7,15N2 | / | Unkown | |
| HY-W334800S2 | (2S,6S)-2,6-Diaminoheptanedioic acid-13C7 | / | Unkown | |
| HY-W753671 | 2,6-Diaminoheptanedioic acid-13C7 | / | Unkown | |
| HY-W767186 | D-Mannoheptulose-13C7 | / | Unkown | |
| HY-W940797 | Thalidomide-O-amido-C7-NH2 | / | Unkown | |
| HY-Y1027S | 2-Chlorobenzoic Acid-13C7 | / | Unkown | |
| HY-100807S1 | Quinolinic acid-13C7 | / | Unkown | |
| HY-103447S2 | Zearalenone-13C7 | Activator | / | Unkown |
| HY-118051 | LY 186826 | / | Unkown | |
| HY-133698 | Lenalidomide-O-C7-COOH | / | Unkown | |
| HY-136186A | (S,R,S)-AHPC-C7-amine dihydrochloride | / | Unkown | |
| HY-14283S | Luliconazole-13C7 | / | Unkown | |
| HY-159204 | 3'-Amino-Modifier C7 CPG 1000 | / | Unkown | |
| HY-162862 | JAK-IN-38 | Inhibitor | / | Unkown |
| HY-180442 | 7-BioQ | / | Unkown | |
| HY-181356 | (S,R,S,R)-AHPC-Me-CO-C7-N3 | / | Unkown | |
| HY-185909 | Dodecanamido C7 Phosphoramidite | / | Unkown | |
| HY-185910 | Palmitamido C7 Phosphoramidite | / | Unkown | |
| HY-B0495S8 | Lamotrigine-13C7,15N | / | Unkown | |
| HY-RS16518 | Cxcl10 Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS17240 | C7 Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS20317 | Oxr1 Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS23694 | C7 Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W278073 | RNA splicing modulator 6 | Modulator | / | Unkown |
| HY-W800743 | Heptyl 6-bromohexanoate | / | Unkown | |
| HY-W939883 | Thalidomide-4-O-C7-Br | / | Unkown |
阻害性抗体
(3)
| 製品番号 | 製品名 |
製品効果
|
純度 |
Rare Diseases
|
|---|---|---|---|---|
| HY-P991608 | CTM01 | Inhibitor | 99.32% | Unkown |
| HY-P991573 | Anti-EGFR Antibody (D2C7) | Inhibitor | / | Unkown |
| HY-P991857 | Anti-Human/Mouse/Bovine ADAM10 Antibody (8C7) | 99.50% | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service